Brief: SSY Group Says China's NMPA Approved Consistency Evaluation Of Quality, Efficacy Of Co's Drug
03/11/2025 10:28
Nov 3 (Reuters) - SSY Group Ltd 2005.HK: CHINA'S NMPA APPROVED PASSING OF CONSISTENCY EVALUATION OF QUALITY AND EFFICACY OF GENERIC DRUGS FOR CO'S DRUG DRUG REFERS TO LINCOMYCIN HYDROCHLORIDE INJECTION Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth